| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |